The efficacy and safety of300 mg bid ranitidine in treatment of duodena/ ulcer
Doç. Dr. Ömer KARAHAN*, Yrd.Doç.Dr. Metin BEL VİRANLI*, Prof.Dr. Adnan KAYNAK*, Yrd. Doç. Dr. Mustafa ŞAHİN**, Araş. Gör. Dr. Cemil ER*
.
Abstract
Twenty patients with duodenal ulcer, measuring at least 5 mm or more in its larger diameter endoscopically were employed 300 mg bid ranitidine for 4 weeks. The patients were assessed endoscopically and symptomatically after 4 weeks. In 16 of 17 (94.1 %) patients, pain was relieved in 1.6 days (mean) and ulcer was healed endoscopically in 4 weeks and no side effect was detected. H e concluded that 300 mg bid ranitidine is more effective and safe. [Journal of Turgut Özal Medical Center 1(2): 108- 111,19941
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
